Abcentra
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1925 Century Park E Ste 1700, Los Angele...Phone Number
(424) 263-6364Website
www.abcentra.comRevenue
<$5 MillionIndustry
About Abcentra
Abcentra Org Chart
Is Abcentra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Abcentra, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Abcentra had a recent Job posting/layoffs
Earning: See what the market has to say on Abcentra recently announced quarterly report
Product Launch: Get notified when Abcentra launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Abcentra
Check out if Abcentra is spiking on competitors!
Funding: Get notified immidiatlly once Abcentra has new funding data
Check if Abcentra has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Abcentra
Find more new buyers
Compare Similar Companies to Abcentra
Compare insights from companies similar to Abcentra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Abcentra is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abcentra is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abcentra.
Abcentra Tech Stack
A closer look at the technologies used by Abcentra
Abcentra News & Media
Abcentra Announces Appointment of Dr. Peter Libby as a Board Member as it Enters Orticumab's Phase 2b Trial (FORTIFY)
LOS ANGELES, June 24, 2025 /PRNewswire/ -- Abcentra LLC (Abcentra), a clinical stage biotechnology company specializing in coronary artery disease, today announced the appointment of Dr. Peter Libby, MD as a Board Member. "We are thrilled to have Dr. Libby join Abcentra's Board. He is a...American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra's Orticumab
Caristo's CaRi-Heart® AI Technology used to monitor effects of Orticumab detected a reduction in coronary inflammation and predicted a 50% reduction in risk of fatal cardiac events among patients with high coronary artery inflammation ATLANTA, April 8, 2024 /PRNewswire/ -- Abcentra LLC, a...Abcentra Appoints Entrepreneur and Cardiologist Michael H. Davidson to Board of Directors
LOS ANGELES, Oct. 14, 2021 /PRNewswire/ -- Abcentra LLC announced today that Michael H. Davidson, MD, has been appointed to the Board of Directors. Dr. Davidson is currently CEO of New Amsterdam Pharma, and was previously the founding CEO and Chief Medical Officer of Corvidia...Abcentra Announces First Patients Dosed with Orticumab in Clinical Trial Evaluating Blockade of Oxidized LDL in Psoriasis with Elevated Cardiometabolic Risk
LOS ANGELES, Aug. 4, 2021 /PRNewswire/ -- Today, Abcentra LLC announced that the first patients have been dosed in its multi-center phase 2 trial assessing the safety and activity of orticumab in patients with moderate-to-severe plaque psoriasis and cardiometabolic risk factors. Orticumab...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abcentra
Abcentra is a clinical-stage bio-pharmaceutical company that addresses unmet needs in inflammation by targeting oxidized lipoproteins.... Read More